Tuberculosis Trial, Recruiting NCT05941052 Sponsor: University of California, San Francisco Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT05941052
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people being checked for tuberculosis (TB):

  • Adults and young people aged 12 or older who are not currently admitted to a hospital, and who have had a cough lasting 2 weeks or more
  • People aged 12 or older who are not hospitalised and who have HIV, report having been in close contact with someone who had TB, or have a history of working in mining — and who also show signs of possible TB based on World Health Organization (WHO) screening tools (such as a blood test result or an abnormal chest X-ray, depending on the risk factor)

For healthcare workers being asked about the usability of TB tests:

  • Health workers aged 18 or older who are involved in routine TB testing at a participating clinic, such as collecting samples or performing TB tests

Who may not be able to join:

For people being checked for TB:

  • People who have completed treatment for either latent (inactive) or active TB within the past 12 months
  • People who have taken any antibiotic or medication that works against TB-related bacteria — including a type called fluoroquinolones — for any reason, within 2 weeks before entering the study
  • People who live more than 20 kilometres from the study site, or who are not willing to return for follow-up visits
  • People who are not willing to give their informed consent to participate

For healthcare workers:

  • Staff who are not willing to give their informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Adithya Cattamanchi, University of California, Irvine

Phone: +1-415-206-5489

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 August 2023
Est. completion
30 September 2028

Where this trial is recruiting

Nigeria 🇵🇭 Philippines Zambia

Primary endpoints

Proportion with positive index test result among participants with tuberculosis (TB); Proportion with negative index test result among participants without tuberculosis (TB)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov